Skip to main content
University of California San Francisco
UCSF School of Medicine | Department of Pediatrics UCSF Medical Center

X-Linked Hypophosphatemia Management in Adults: An International Working Group Clinical Practice Guideline.

  • Read more about X-Linked Hypophosphatemia Management in Adults: An International Working Group Clinical Practice Guideline.

Current Practices in Monitoring Children and Adults with X-linked Hypophosphatemia: A Global Survey of Expert Experience.

  • Read more about Current Practices in Monitoring Children and Adults with X-linked Hypophosphatemia: A Global Survey of Expert Experience.

X-Linked Hypophosphatemia Management in Children: An International Working Group Clinical Practice Guideline.

  • Read more about X-Linked Hypophosphatemia Management in Children: An International Working Group Clinical Practice Guideline.

Revolutionizing OGTT: Unlocking the Real-time Insights and Expanded Data of Continuous Glucose Monitoring (CGM).

  • Read more about Revolutionizing OGTT: Unlocking the Real-time Insights and Expanded Data of Continuous Glucose Monitoring (CGM).

Disordered electron transfer: New forms of defective steroidogenesis and mitochondriopathy.

  • Read more about Disordered electron transfer: New forms of defective steroidogenesis and mitochondriopathy.

Development of 24-hour rhythms in cortisol secretion across infancy: a systematic review and meta-analysis of individual participant data.

  • Read more about Development of 24-hour rhythms in cortisol secretion across infancy: a systematic review and meta-analysis of individual participant data.

Effect of Hormone Therapy on Lipoprotein Subfractions in Early and Late Postmenopausal Women.

  • Read more about Effect of Hormone Therapy on Lipoprotein Subfractions in Early and Late Postmenopausal Women.

Burosumab Versus Phosphate/Active Vitamin D in Pediatric X-Linked Hypophosphatemia: A Sub-group Analysis by Dose Level.

  • Read more about Burosumab Versus Phosphate/Active Vitamin D in Pediatric X-Linked Hypophosphatemia: A Sub-group Analysis by Dose Level.

Long-term Burosumab Administration Is Safe and Effective in Adults With X-linked Hypophosphatemia.

  • Read more about Long-term Burosumab Administration Is Safe and Effective in Adults With X-linked Hypophosphatemia.

Sustained efficacy and safety of burosumab, a monoclonal antibody to FGF23, in children with X-linked hypophosphatemia.

  • Read more about Sustained efficacy and safety of burosumab, a monoclonal antibody to FGF23, in children with X-linked hypophosphatemia.

Pagination

  • Page 1
  • Next page ››
Subscribe to The Journal of clinical endocrinology and metabolism

Pediatrics Home

MAKE A GIFT

© 2022 The Regents of the University of California. The University of California San Francisco  |  UCSF Department of Pediatrics                                                                                              Accessibility  Privacy Policy  Terms of Use  A-Z Website List